UTHR director exercises options, sells 1,000 shares
UNITED THERAPEUTICS director Christopher Patusky exercised stock options and sold shares in a planned transaction.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
UNITED THERAPEUTICS director Christopher Patusky exercised stock options and sold shares in a planned transaction. He exercised 1,000 stock options at an exercise price of $101.80 per share, then sold 1,000 common shares at $578.88 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he holds 1,490 common shares directly and 1,100 shares indirectly through a trust.
Insider Trade Summary 10b5-1
Exercise and Sale: 1,000 shares ($477K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
PATUSKY CHRISTOPHER
Role
Director
Sold
1,000 shs ($579K)
Approx. gross sale proceeds
$579K
Approx. exercise cost
$102K
Approx. pre-tax spread
$477K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 1,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,000 | $101.80 | $102K |
| Sale | Common Stock | 1,000 | $578.88 | $579K |
| Holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option — 2,910 contracts (Direct);
Common Stock — 1,490 shares (Direct);
Common Stock — 1,100 shares (Indirect, by Trust)
Footnotes (1)
- F1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025.
Key Figures
Options exercised: 1,000 shares
Option exercise price: $101.80 per share
Shares sold: 1,000 shares
+5 more
8 metrics
Options exercised
1,000 shares
Stock options converted to common stock on April 17, 2026
Option exercise price
$101.80 per share
Exercise price of stock options exercised April 17, 2026
Shares sold
1,000 shares
Open-market sale of common stock on April 17, 2026
Sale price
$578.88 per share
Price for open-market sale of 1,000 common shares
Direct holdings after
1,490 shares
Common stock directly owned after transactions
Indirect holdings after
1,100 shares
Common stock indirectly owned by trust after transactions
Option exercise date
June 21, 2017
Original exercise start date of stock options
Option expiration
June 21, 2026
Expiration date of stock options exercised
Key Terms
Stock Option, open-market sale, Rule 10b5-1 trading plan, indirect, +1 more
5 terms
Stock Option financial
"security_title": "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Rule 10b5-1 trading plan regulatory
"exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
indirect financial
"ownership_type": "indirect""
by Trust financial
"nature_of_ownership": "by Trust""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did UNITED THERAPEUTICS (UTHR) director Christopher Patusky report?
Christopher Patusky reported exercising 1,000 stock options, then selling 1,000 UNITED THERAPEUTICS common shares. The exercise price was $101.80 per share and the sale price was $578.88 per share, all on April 17, 2026.
What prices were involved in Christopher Patusky’s UNITED THERAPEUTICS (UTHR) Form 4 transactions?
The stock options were exercised at an exercise price of $101.80 per share. The 1,000 UNITED THERAPEUTICS common shares acquired from the exercise were then sold at a transaction price of $578.88 per share in an open-market sale on the same date.
What type of securities did Christopher Patusky transact in for UNITED THERAPEUTICS (UTHR)?
He exercised derivative securities described as a “Stock Option” into 1,000 shares of UNITED THERAPEUTICS common stock. He then sold 1,000 shares of that common stock in an open-market transaction, as reflected by the transaction code “S” for sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.
